Table 2.
Application of immune cell-based DDS in glioma
| Immune cells | Components | Loaded drugs/nanoparticles | Methods | Model in vivo | Functions | References |
|---|---|---|---|---|---|---|
| Monocyte | Cell | Conjugated polymer nanoparticles | Trojan horse | GL261 orthotopic gliomas mice model |
Target BBB and tumor Increase the PDT treatment efficacy |
[86] |
| Monocyte | Cell | Nano-DOX | Trojan horse | Orthotopic GBM xenografts mice model |
Target BBB and tumor cells Induce tumor cell damage by promoting DAMP emission |
[87] |
| Macrophage | Cell | Photothermal nanoprobe (MFe3O4-Cy5.5) | Trojan horse | C6 orthotopic gliomas rat model |
Target BBB and tumor, and penetrate deeply Perform fluorescence, photoacoustic, and magnetic resonance imaging Induce local photothermal therapy Inhibit the recurrence of glioma after surgery |
[88] |
| Macrophage | Cell | C6/Dir loaded nanoparticles | Trojan horse | U87 orthotopic gliomas mice model |
Target BBB and tumor Promote deeper permeation in tumor tissue |
[89] |
| Macrophage | Cell | Dox | Trojan horse | – | Enhance drug release efficacy from macrophage by photochemical internalization | [90] |
| Macrophage | Cell | β-Glucans prodrug nanoparticles | Trojan horse | ALTS1C1 and LCPN orthotopic gliomas mice model |
Target BBB and tumor cells Glutathione responsive drug release Suppress tumor growth and prolong survival time |
[91] |
| M2 macrophage | Cell | Nano-DOX | Trojan horse | Orthotopic GBM xenografts mice model |
Target BBB and tumor Modulate tumor immune microenvironment Suppress tumor growth |
[92] |
| M1 macrophage | Cell | DOX-loaded PLGA nanoparticles | Trojan horse | U87 intracranial glioma-bearing mice model |
Target BBB and tumor cells Induce tumor cell apoptosis Suppress tumor growth and prolong survival time |
[93] |
| Macrophage | Membrane | MnO2 and cisplatin-loaded redox-responsive poly(N-vinylcaprolactam) nanogels |
Hypotonic lysis/freeze–thaw/centrifugation Co-extrusion |
C6 orthotopic brain glioma model |
Target BBB Deplete excess glutathione Exhibit magnetic resonance imaging-guided chemotherapy/chemodynamic therapy |
[94] |
| Macrophage | Membrane | DSPE-PEG-loaded IR-792 nanoparticles |
Lysis buffer, sonication, and centrifugation Co-extrusion |
U87L orthotopic GBM model |
Target BBB and tumor Suppress tumor growth and prolong survival time |
[95] |
| PD-1 overexpressed macrophage | Membrane | RAPA-loaded PLGA nanoparticles |
Homogenization and centrifugation Co-extrusion |
C6-Luc orthotopic gliomas mice model |
Target BBB and the tumor microenvironment Block the immune checkpoint Activate the CD8+ CTL |
[96] |
| M1-macrophage | Extracellular vesicles | CPPO and Ce6 modified and hypoxia-activated prodrug AQ4N | Incubation, ultracentrifugation, incubation and ultrafiltration (Pre-and post-loading) | Orthotopic gliomas mice model |
Target BBB and tumor cells Modulate the immunosuppressive tumor microenvironment The chemiexcited photodynamic therapy and hypoxia-activated chemotherapy |
[97] |
| Macrophage | Exosomes | SPIONs) and Cur | Differential centrifugation and ultrafiltration; Electroporation (post-loading) | U251 orthotopic gliomas mice model | Target BBB and tumor | [98] |
| Functionalized macrophage | Exosomes | Panobinostat and PPM1D-siRNA loaded positively charged micelles |
Centrifugation and ultrafiltration; Hypotonic lysis Co-extrusion |
Orthotopic DIPG-bearing mice |
Target BBB and tumor Suppress tumor growth and prolong survival time |
[99] |
| Microglia | Cell | PTX loaded liposome | Trojan horse | U87 MG and GL261 orthotopic gliomas mice model |
Target BBB and tumor Transport drug to glioma cells via extracellular vesicles and tunneling nanotubes Suppress tumor progression |
[100] |
| Microglia | Membrane | ZOL loaded nanoparticle | Mechanical crushing; Co-extrusion | GL261/TR orthotopic gliomas mice model |
Target BBB and tumor cells Inducing apoptosis and inhibiting the migration and invasion of temozolomide-resistant GBM cells Improve the immunosuppressive and hypoxic microenvironment |
[101] |
| Microglia | Membrane | Fe3O4-siPD-L1 | Hypotonic lysis/freeze–thaw/centrifugation; Sonication and co-exclusion | Luc-GL261/TR orthotopic gliomas mice model |
Target BBB and tumor cells Increase effector T cells and M1-type microglia Induce ferroptosis of GBM cells and maturation of DC cell Suppress tumor growth and prolong survival time |
[102] |
| Neutrophil | Cell | PTX loaded cationic liposome | Trojan horse | Glioma surgical resection model |
Target inflamed regions in brain and tumor cells Inflammatory responsive drug release Suppress the recurrence and improve survival rates |
[103] |
| Neutrophil | Cell | DOX-loaded magnetic mesoporous silica nanoparticles | Trojan horse | Glioma surgical resection model |
Target inflamed regions in brain and tumor cells Suppress tumor growth and prolong survival time Promote tumor cells and TAM apoptosis |
[104] |
| Neutrophil | Cell | Escherichia coli membrane-enveloped, PTX-loaded magnetic nanogels | Trojan horse | Glioma surgical resection model |
Target inflamed regions in brain and tumor cells Inhibit the proliferation of tumor cells |
[105] |
| Neutrophil | Cell | PTX and anti-PD-1 antibody-loaded nanosensitizer | Trojan horse | GL261 tumor-bearing C57BL/6 mice |
Target inflamed regions in brain and tumor cells Ultrasound responsive drug release Kill tumor and induce local inflammation Improve survival rates |
[106] |
| Neutrophil | Exosomes | DOX | Centrifugal and filter separation, Sonication, and incubation (post-loading) | Zebrafish and C6-Luc glioma-bearing mice models |
Target BBB and tumor cells Suppress tumor growth and prolong survival time |
[107] |
| Neutrophil/ Macrophage | Membrane | RAPA-loaded PLGA nanoparticles | Hypotonic lysis and homogenizer; Sonication and co-extrusion | C6-Luc glioma-bearing mice models |
Target inflamed regions in brain and tumor cells Eliminating glioma cells and inducing durable tumor regression |
[108] |
| NK cell | Membrane | AIE nanoparticles | Lysis buffer/differential ultracentrifugation and co-extrusion | Orthotopic glioma models |
Target BBB and tumor cells Trigger TJs disruption and actin cytoskeleton reorganization Suppress tumor growth |
[109] |
| DC cell | Cell | Nano-DOX | Trojan horse | Orthotopic human GBM xenografts mice model |
Target BBB and tumor Enhance DC-driven anti-GBM immune response |
[110] |
| DC cell | membrane | RAPA-loaded PLGA nanoparticles |
Lysis buffer and centrifugation Co-extrusion |
C6-Luc glioma C57 mice |
Target BBB and tumor Enhance immune response Suppress tumor growth and prolong survival time |
[111] |
| DC cell | C6 and DC membrane | DTX nanosuspensions | Hypotoniclysis/freeze–thaw/differential ultracentrifugation and sonication | Intracranial glioma- mouse model |
Target BBB and tumor Enhance DTX anti-tumor efficiency Activate downstream immune system |
[112] |
AIE aggregation-induced emission, BBB blood–brain barrier, CPPO bis(2,4,5-trichloro-6-carbopentoxyphenyl) oxalate, CTL cytotoxic T-lymphocyte, Cur curcumin, DAMP damage-associated molecular patterns, DC dendritic cell, DIPG diffuse intrinsic pontine glioma, Dir 1,1′-dioctadecyl-3,3,3′,3′-tetramethyl indotricarbocyanine Iodide, DOX doxorubicin, DSPE-PEG 1,2-Distearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethyleneglycol)-2000], DTX docetaxel, C6-Luc C6 glioma cells that luciferase reporter-gene labeled, GBM glioblastoma, PD-1 programmed cell death-1, PDT photodynamic therapy, PLGA poly(lactic-co-glycolic acid), PPM1D protein phosphatase 1, PTX paclitaxel, RAPA Rapamycin, SPIONs superparamagnetic iron oxide nanoparticles, TAM tumor-associated macrophages, TJs tight junctions, ZOL Zoledronate. “–” represent no mentioned